M E Hill

Author PubWeight™ 49.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature 1981 6.18
2 Childhood conditions that predict survival to advanced ages among African-Americans. Soc Sci Med 1998 2.48
3 A treatable form of dementia due to normal-pressure, communicating hydrocephalus. Can Med Assoc J 1967 2.06
4 Voyager 1 in the foreshock, termination shock, and heliosheath. Science 2005 1.75
5 Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy. Eur J Cancer 2006 1.66
6 Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003 1.61
7 Chemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neck. Ann Oncol 1997 1.53
8 Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer 2005 1.47
9 A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary. Eur J Cancer 2003 1.45
10 Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer 2002 1.45
11 Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma. Ann Oncol 2004 1.34
12 The Mendelian inheritance of a human X chromosome-specific DNA sequence polymorphism and its use in linkage studies of genetic disease. Hum Genet 1982 1.34
13 Voyager 1 exited the solar wind at a distance of approximately 85 Au from the Sun. Nature 2003 1.16
14 Recombinant human monocyte IL-8 primes NADPH-oxidase and phospholipase A2 activation in human neutrophils. Immunology 1992 1.15
15 Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan. Br J Cancer 2005 1.11
16 Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 2002 1.05
17 Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: response, toxicity, quality of life, and survival. Cancer 1996 0.98
18 Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer. Br J Cancer 2004 0.95
19 Solitary pancreatic metastasis from a primary colonic tumor detected by PET scan: report of a case. Dis Colon Rectum 2001 0.92
20 Re: "Comparison of National Death Index and world wide web death searches". Am J Epidemiol 2001 0.92
21 Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass: a preliminary analysis. J Surg Res 2001 0.91
22 A human cDNA sequence with homology to non-mammalian lysophosphatidic acid acyltransferases. Biochem J 1997 0.91
23 Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease. Br J Cancer 1997 0.87
24 Priming of the oxidative burst in human neutrophils by physiological agonists or cytochalasin B results from the recruitment of previously non-responsive cells. Immunology 1994 0.87
25 Knowledgeable, consistent, competent care: meeting the challenges of delivering quality cancer care in remote northern communities. Int J Circumpolar Health 2001 0.85
26 High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma. Br J Cancer 1993 0.85
27 Surgery plus chemotherapy or chemotherapy alone for primary intermediate- and high-grade gastric non-Hodgkin's lymphoma: the Royal Marsden Hospital experience. Eur J Cancer 1999 0.85
28 Agonist-stimulated Cl- efflux from human neutrophils. A common phenomenon during neutrophil activation. Biochem Pharmacol 1993 0.84
29 Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. Diabetes 2000 0.83
30 Toward a definition of HIV expertise: a survey of experienced HIV physicians. AIDS Patient Care STDS 2001 0.83
31 Hypoplasia of the abdominal aorta associated with rubella syndrome. South Med J 1979 0.82
32 Mediation of the solar wind termination shock by non-thermal ions. Nature 2008 0.81
33 Combining platinum, paclitaxel and anthracycline in patients with advanced gynaecological malignancy. Eur J Cancer 2000 0.80
34 Irradiation for progressive paraparesis in B-thalassemia intermedia. Can Med Assoc J 1980 0.80
35 GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanoma. Ann Oncol 2000 0.78
36 Thymus, thymoma, and specific T cells in myasthenia gravis. Ann N Y Acad Sci 1998 0.77
37 Biologic properties and therapeutic potential of glucagon-like peptide-2. JPEN J Parenter Enteral Nutr 1999 0.77
38 Inhibitory action of sphingosine, sphinganine and dexamethasone on glucose uptake: studies with hydrogen peroxide and phorbol ester. Life Sci 1990 0.77
39 Differential regulation of early phase and late phase responses in human neutrophils by cAMP. Biochem Pharmacol 1993 0.76
40 Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses? Eur J Cancer 2000 0.75
41 An unusual familial oculopharyngeal syndrome. Eur J Neurol 2006 0.75
42 Survival after systemic therapy for metastatic colorectal cancer. Lancet 1995 0.75
43 Clinical use of droperidol in pneumoencephalography. Can Med Assoc J 1968 0.75
44 ECF in gastric cancer. J Clin Oncol 2000 0.75
45 Search for the exit: Voyager 1 at heliosphere's border with the galaxy. Science 2013 0.75
46 Anti-sense to secretory type II phospholipase A2 inhibits fMLP induced arachidonic acid release in differentiated HL-60's. Biochem Soc Trans 1994 0.75
47 Letter: Myotonia associated with small cell carcinoma of the lung. Arch Neurol 1976 0.75
48 A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus. Ann Oncol 2002 0.75
49 A rare case of intravascular lymphoma diagnosed on bone marrow trephine. Leuk Lymphoma 2003 0.75
50 An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease. Ann Vasc Surg 1988 0.75
51 Energetic particles in the jovian magnetotail. Science 2007 0.75
52 Patient education: how to establish a low-cost program. Tex Hosp 1983 0.75
53 Inhibition of neutrophil priming by inhibitors of farnesyl transferase. Biochem Soc Trans 1997 0.75
54 Differential effects of CB1 and CB2 agonists on cAMP levels and MAP kinase activation in human peripheral blood mononuclear cells. Biochem Soc Trans 1997 0.75